Novonesis A/S's latest marketcap:
As of 06/26/2025, Novonesis A/S's market capitalization has reached $34.27 B. According to our data, Novonesis A/S is the 633th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 34.27 B |
| Revenue (ttm) | 4.74 B |
| Net Income (ttm) | 535.7 M |
| Shares Out | 462.9 M |
| EPS (ttm) | 1.85 |
| Forward PE | 30.20 |
| Ex-Dividend Date | 04/04/2025 |
| Earnings Date | 08/21/2025 |
Novonesis A/S's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | kr34.27 B | 14.53% | 633 |
| 12/30/2024 | kr189.43 B | 84.24% | 731 |
| 12/29/2023 | kr102.82 B | 5.66% | 1143 |
| 12/30/2022 | kr97.3 B | -34.61% | 1136 |
| 12/30/2021 | kr148.8 B | 51.92% | 895 |
| 12/30/2020 | kr97.94 B | 6.81% | 1065 |
| 12/30/2019 | kr91.7 B | 9.61% | 1006 |
| 12/28/2018 | kr83.66 B | -19.43% | 872 |
| 12/29/2017 | kr103.83 B | 43.33% | 780 |
| 12/30/2016 | kr72.44 B | -27.74% | 983 |
Company Profile
About Novonesis A/S
Novonesis A/S is a global leader in producing and selling industrial enzymes, functional proteins, and microorganisms. Headquartered in Bagsvaerd, Denmark, the company serves markets across Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America.
Key Offerings
Biosolutions for Food & Beverage:
- Dairy, baking, beverage, and meat processing
- Plant-based and functional foods
- Protein solutions and early-life nutrition
Industrial & Household Solutions:
- Industrial hygiene and cleaning products
- Drain openers, hard surface cleaners, and medical cleaning
- Septic tank treatments and professional laundry services
- Dishwashing and fabric softeners
Agricultural & Aquaculture Solutions:
- Crop solutions for corn, cotton, soybeans, wheat, and more
- Bioyield and biocontrol products
- Warm-water species and recirculating aquaculture systems
- Animal health and nutrition
Industrial & Environmental Solutions:
- Carbon capture and textile processing
- Enzyme solutions for biofuel production
- Wastewater and sewage treatment
- Biogas and food waste management
Human Health Solutions:
- Brain, oral, and gastrointestinal health products
- Protective and immune health solutions
Enzyme Specialties:
- Lipases, proteases, oxidoreductases, and carbohydrases
Founded in 1925, Novonesis A/S continues to innovate in biotechnology, providing sustainable solutions across multiple industries.
Frequently Asked Questions
-
What is Novonesis A/S's (CPH-NSIS.B) current market cap?As of 06/26/2025, Novonesis A/S (including the parent company, if applicable) has an estimated market capitalization of $34.27 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Novonesis A/S (CPH-NSIS.B) rank globally by market cap?Novonesis A/S global market capitalization ranking is approximately 633 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.